New York City, NY -- (SBWIRE) -- 12/12/2013 -- StockMarketIntel.com issues a special report on the following stocks: Globalstar, Inc. (OTCMKTS:GSAT), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), CytRx Corporation (NASDAQ:CYTR), Cereplast Inc (OTCMKTS:CERP)
Globalstar, Inc. (OTCMKTS:GSAT) gained 6.40%, trading on 21.66 million shares, to end the trade at $1.83. The stock changed hands in a range of $1.72 to $1.84, bringing its market capitalization to about $1.37 billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.25 and was moved to the maximum level of $1.84. Globalstar, Inc. provides mobile voice and data communications services through satellite worldwide. The company offers duplex two-way voice and data products, including mobile voice and data satellite communications services and equipment for remote business continuity, recreational, emergency response, and other applications; fixed voice and data satellite communications services in rural villages, ships, industrial and commercial sites, and residential sites; and satellite data modem services comprising asynchronous and packet data services.
What was the Moving Force behind GSAT on Bullish Run? Read This Research Report
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) declined -8.33%, to complete the trading session at $4.07, with a total volume of 16.40 million shares. The stock, on average, trades on a volume of 23.07 million shares. It floated in a range of $3.98 to $4.48 during the last trading session, with a beta value of 0.81. Its market capitalization now moved to about $755.62 million. In the past 52 weeks, the share price has not declined below $2.15 and above $24.59. ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients. The company focuses on commercializing Iclusig (ponatinib), a cancer medicine; and developing additional molecularly targeted therapies to treat patients with blood cancers and solid tumors.
Has ARIA Found The Bottom and Ready To Move Up? Find Out Here
CytRx Corporation (NASDAQ:CYTR) recorded a gain of 68.20% and was in a range of $3.45-$4.38 before closing at $4.02. The stock completed the day with a total volume of 31.83 million shares, versus an average volume of 633,151 shares. The share price hit its 52-week low of $1.80 and $4.38 was the best price. CytRx Corporation is a biopharmaceutical research and development company specializing in oncology. Its oncology pipeline includes two programs, aldoxorubicin and tamibarotene, which are in clinical development for cancer indications.
For How Long CYTR will fight for Profitability? Read This Trend Analysis report
Cereplast Inc (OTCMKTS:CERP) added 9.26% yesterday, bringing its market capitalization around $4.25 billion. The share price, after opening at $0.01, made a high of $0.01 and hovered above $0.01 to end the day at $0.0059. The total number of shares that changed hands during the session was 27.15 million shares, as compared to average trading volume of 13.43 million shares. Cereplast, Inc. develops and commercializes bio-based resins. It provides Cereplast Compostables resins, which are compostable, bio-based, and ecologically sound substitutes for petroleum-based plastics targeting compostable bags, single-use food service products, and packaging applications.
For How Long CERP Gloss will Attract Investors? Find out via this report
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)